Zoetis (BSP:Z1TS34) Other Current Liabilities : R$2,372 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Zoetis Other Current Liabilities?

Zoetis's other current liabilities for the quarter that ended in Dec. 2023 was R$2,372 Mil.

Zoetis's quarterly other current liabilities increased from Jun. 2023 (R$1,718 Mil) to Sep. 2023 (R$1,882 Mil) and increased from Sep. 2023 (R$1,882 Mil) to Dec. 2023 (R$2,372 Mil).

Zoetis's annual other current liabilities declined from Dec. 2021 (R$2,596 Mil) to Dec. 2022 (R$2,082 Mil) but then increased from Dec. 2022 (R$2,082 Mil) to Dec. 2023 (R$2,372 Mil).

Zoetis Other Current Liabilities Historical Data

The historical data trend for Zoetis's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Other Current Liabilities Chart

Zoetis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Zoetis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Zoetis Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Zoetis Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Zoetis's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoetis (BSP:Z1TS34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (BSP:Z1TS34) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

ZTS:USA ZTS:Mexico 1ZTS:Italy ZOE:Germany

Address

10 Sylvan Way, Parsippany, NJ, USA, 07054

Website

https://www.zoetis.com

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (BSP:Z1TS34) Headlines

No Headlines